GlassScriptPhysician profile
Steven Richard Scheufler
NPI 1447231428
$2,725.37
in general payments reported to CMS, 2019-2025
26 companies · $33.01 in 2025
The $33.01 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,603 · 2020: $1,090 · 2025: $33.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $516.04 | 2019-2020 | |
| Novo Nordisk INC | $386.23 | 2019-2025 | |
| Amgen INC. | $259.48 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $211.03 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $172.81 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $163.00 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $157.16 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.92 | 2019-2020 | |
| Pfizer INC. | $133.95 | 2019-2020 | |
| Abbvie INC. | $93.01 | 2019-2020 | |
| Astellas Pharma US INC | $84.31 | 2019-2020 | |
| Amarin Pharma, INC. | $69.23 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $58.87 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $58.08 | 2020 | |
| Shire North American Group INC | $30.55 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $29.51 | 2019 | |
| Ironwood Pharmaceuticals, INC | $28.84 | 2020 | |
| Radius Health, INC. | $28.80 | 2019-2020 | |
| Insulet Corporation | $18.49 | 2025 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.61 | 2019 | |
| Daiichi Sankyo INC. | $13.33 | 2020 | |
| Eisai INC. | $12.25 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.76 | 2020 | |
| Allergan, INC. | $11.26 | 2019 | |
| Sanofi Pasteur INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Scheufler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.